AN ACT to create and enact a new section to chapter 50-25.1 of the North Dakota Century Code, relating to an exemption for postpartum exposure to controlled substances and alcohol; to amend and reenact sections 50-25.1-16 and 50-25.1-17 of the North Dakota Century Code, relating to reporting requirements for prenatal exposure to controlled substances and alcohol abuse and toxicology test requirements; and to repeal section 50-25.1-18 of the North Dakota Century Code, relating to reporting requirements for prenatal exposure to alcohol misuse.
SB2232 revises North Dakota’s child welfare and mandatory reporting rules for substance exposure during pregnancy and after delivery. The bill amends existing law on prenatal exposure to controlled substances and alcohol misuse, and it creates a new reporting exemption for postpartum women when professionals are actively providing or coordinating prenatal, postnatal, or substance use treatment services, including voluntary admission to a licensed treatment program. Under the bill, reporting is still required if the woman stops regular prenatal or postnatal care, fails to follow treatment recommendations, or continues substance misuse.
The bill also changes toxicology testing provisions. It allows physicians to administer toxicology tests to pregnant women, women within eight hours after delivery, and newborns when there is a medical basis to suspect controlled substance use or alcohol misuse, and it preserves reporting obligations when test results or other evidence indicate exposure. The bill repeals a separate section dealing with reporting requirements for prenatal alcohol misuse, consolidating and updating the reporting framework within chapter 50-25.1.
SB2232 would modify North Dakota Century Code chapter 50-25.1 by narrowing mandatory reporting in some treatment settings, clarifying when reports must still be made, and updating physician toxicology-testing authority and immunity provisions. It affects mandated reporters, physicians, hospitals, child welfare agencies, pregnant and postpartum women, newborns, and substance use treatment providers by tying reporting exemptions to active participation in care and treatment compliance. It also repeals section 50-25.1-18, removing a separate prenatal alcohol misuse reporting provision and folding related requirements into the amended sections.
The bill appears to have broad support in the Senate, passing 44-2, but a more divided reception in the House, where it passed 57-36. That voting pattern suggests general agreement on the need to update reporting and treatment-related rules, but with meaningful concern about how the bill balances public health treatment approaches against child protection and mandatory reporting obligations. The absence of recorded committee transcripts limits insight into detailed debate, but the final votes indicate the measure was supported overall while still drawing notable opposition.
The main point of contention is the bill’s treatment-based exemption from reporting. Supporters likely view the exemption as encouraging pregnant and postpartum women to seek care without immediate reporting when they are cooperating with providers and entering treatment, while opponents may worry that the exemption could delay intervention in cases of ongoing substance use or risk to infants. Another likely area of disagreement is the expanded and clarified toxicology-testing authority, especially the ability to test newborns and postpartum women based on medical suspicion and to report positive results as neglect. The House vote margin suggests these public health versus child welfare concerns were the most significant dividing line.